These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8082563)

  • 21. The metabolic activation of 2-aminofluorine, 4-aminobiphenyl, and benzidine by cytochrome P-450-107S1 of Pseudomonas aeruginosa.
    Adris P; Lopez-Estraño C; Chung KT
    Toxicol In Vitro; 2007 Dec; 21(8):1663-71. PubMed ID: 17826028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulatory mechanisms in the activation of nitrogenous compounds by mammalian cytochrome P-450 isozymes.
    Hlavica P
    Drug Metab Rev; 1994; 26(1-2):325-48. PubMed ID: 8082573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic activation of bladder procarcinogens, 2-aminofluorene, 4-aminobiphenyl, and benzidine by Pseudomonas aeruginosa and other human endogenous bacteria.
    Adris P; Chung KT
    Toxicol In Vitro; 2006 Apr; 20(3):367-74. PubMed ID: 16203120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic activation of the potent carcinogen dibenzo[a,h]anthracene by cDNA-expressed human cytochromes P450.
    Shou M; Krausz KW; Gonzalez FJ; Gelboin HV
    Arch Biochem Biophys; 1996 Apr; 328(1):201-7. PubMed ID: 8638931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An improved and updated version of the compact procedure for the evaluation of P450-mediated chemical activation.
    Lewis DF; Ioannides C; Parke DV
    Drug Metab Rev; 1998 Nov; 30(4):709-37. PubMed ID: 9844807
    [No Abstract]   [Full Text] [Related]  

  • 26. Cytochromes P-450 and the activation and inactivation of mutagens and carcinogens.
    Strobel HW; Fang WF; Takazawa RS; Stralka DJ; Newaz SN; Kurzban GP; Nelson DR; Beyer RS
    Basic Life Sci; 1986; 39():61-71. PubMed ID: 3094496
    [No Abstract]   [Full Text] [Related]  

  • 27. Activation of carcinogens by human liver cytochromes P-450.
    Guengerich FP; Shimada T; Iwasaki M; Butler MA; Kadlubar FF
    Basic Life Sci; 1990; 53():381-96. PubMed ID: 2282045
    [No Abstract]   [Full Text] [Related]  

  • 28. Activation of procarcinogens by human cytochrome P450 enzymes.
    Guengerich FP; Shimada T
    Mutat Res; 1998 May; 400(1-2):201-13. PubMed ID: 9685642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytochromes P450 and species differences in xenobiotic metabolism and activation of carcinogen.
    Lewis DF; Ioannides C; Parke DV
    Environ Health Perspect; 1998 Oct; 106(10):633-41. PubMed ID: 9755138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The metabolism of 1-nitropyrene by human cytochromes P450.
    Howard PC; Aoyama T; Bauer SL; Gelboin HV; Gonzalez FJ
    Carcinogenesis; 1990 Sep; 11(9):1539-42. PubMed ID: 2205409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of cytochrome P4501 as an indicator of potential chemical carcinogenesis.
    Ioannides C; Parke DV
    Drug Metab Rev; 1993; 25(4):485-501. PubMed ID: 8313839
    [No Abstract]   [Full Text] [Related]  

  • 32. The cytochromes P-448--a unique family of enzymes involved in chemical toxicity and carcinogenesis.
    Ioannides C; Parke DV
    Biochem Pharmacol; 1987 Dec; 36(24):4197-207. PubMed ID: 3318843
    [No Abstract]   [Full Text] [Related]  

  • 33. Metabolic activation capacity of neonatal mice in relation to the neonatal mouse tumorigenicity bioassay.
    Fu PP; Von Tungeln LS; Hammons GJ; McMahon G; Wogan G; Flammang TJ; Kadlubar FF
    Drug Metab Rev; 2000 May; 32(2):241-66. PubMed ID: 10774778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of cytochrome P450 cDNAs in human B lymphoblastoid cells: applications to toxicology and metabolite analysis.
    Crespi CL
    Methods Enzymol; 1991; 206():123-9. PubMed ID: 1784204
    [No Abstract]   [Full Text] [Related]  

  • 35. The mode of action of organic carcinogens on cellular structures.
    Luch A
    EXS; 2006; (96):65-95. PubMed ID: 16383015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes.
    Guengerich FP; Shimada T
    Chem Res Toxicol; 1991; 4(4):391-407. PubMed ID: 1912325
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of carcinogen-metabolizing enzyme polymorphisms in cancer susceptibility.
    Gonzalez FJ
    Reprod Toxicol; 1997; 11(2-3):397-412. PubMed ID: 9100315
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of cytochrome P-450 monooxygenases in the activation of chemical carcinogens.
    Gil L; Salazar I; Vásquez H; Lara M
    Arch Biol Med Exp; 1988 Jun; 21(1):135-43. PubMed ID: 3154854
    [No Abstract]   [Full Text] [Related]  

  • 39. Induction of cytochrome P 450 I and its influences in chemical carcinogenesis.
    Ioannides C
    Biochem Soc Trans; 1990 Feb; 18(1):32-4. PubMed ID: 2185082
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pharmacogenetics of cytochromes P450: practical implications].
    Jaillon P
    Arch Pediatr; 2001 May; 8 Suppl 2():350s-352s. PubMed ID: 11394113
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.